Dimachkie , Mazen M., et al. “Phase II Study of Arimoclomol in IBM FDA-OOPD ”. RRNMF Neuromuscular Journal, vol. 2, no. 3, Aug. 2021, pp. 104-42, https://doi.org/10.17161/rrnmf.v2i3.15728.